当前位置： SCI文献检索 > BIOCHIMIE期刊下所有文献 > Pathophysiological functions of cathepsin D: Targeting its catalytic activity versus its protein binding activity?

Pathophysiological functions of cathepsin D: Targeting its catalytic activity versus its protein binding activity?

Abstract：

:The lysosomal aspartic protease cathepsin D (cath-D) is overexpressed and hyper-secreted by epithelial breast cancer cells. This protease is an independent marker of poor prognosis in breast cancer as it is correlated with the incidence of clinical metastasis. In normal cells, cath-D is localized in intracellular vesicles (lysosomes and endosomes). In cancer cells, overexpressed cath-D accumulates in cells, where it may affect their degradative capacities, and the pro-enzyme is hyper-secreted in the tumor micro-environment. In addition, during apoptosis, lysosomal cath-D is released into the cytosol, where it may interact with and/or cleave pro-apoptotic, anti-apoptotic, or nuclear proteins. Several studies have shown that cath-D affects various different steps in tumor progression and metastasis. Cath-D stimulates cancer cell growth in an autocrine manner, and also cath-D plays a crucial paracrine role in the tumor micro-environment by stimulating fibroblast outgrowth and tumor angiogenesis. A mutant D231N-cath-D, which is devoid of catalytic activity, remained mitogenic, indicating an additional action of cath-D by protein-protein interaction. Targeting cath-D in cancer may require the use of inhibitors of its catalytic activity, but also the development of new tools to inhibit its protein binding functions. Thus, elucidation of the mechanism of action of cath-D is crucial if an appropriate strategy is to be developed to target this protease in cancer. The discovery of new physiological substrates of cath-D using proteomic approaches can be expected to generate new critical targets. The aim of this review is to describe the roles of the cath-D protease in cancer progression and metastasis, as well as its function in apoptosis, and to discuss how it can be targeted in cancer by inhibiting its proteolytic activity and/or its binding protein activity.

journal_name

Biochimie

journal_title

Biochimie

authors

Masson O,Bach AS,Derocq D,Prébois C,Laurent-Matha V,Pattingre S,Liaudet-Coopman E

doi

10.1016/j.biochi.2010.05.009

subject

Has Abstract

pub_date

2010-11-01 00:00:00

pages

1635-43

issue

eissn

0300-9084

issn

1638-6183

pii

S0300-9084(10)00203-8

journal_volume

pub_type

杂志文章,评审

在线工具

Pathophysiological functions of cathepsin D: Targeting its catalytic activity versus its protein binding activity?